ENABLING NCI CLINICAL & RESEARCH DATA SHARING
ENABLING NCI CLINICAL & RESEARCH DATA SHARING
批准号:
10674469
负责人:
ETHAN DMITROVSKY
金额:
$1521.99万
依托单位国家:
美国
项目类别:
财政年份:
2021
资助国家:
美国
项目状态:
已结题
起止时间:
2021-08-31 至 2023-08-30
关键词:
Adolescent and Young AdultAgeCancer BurdenCancer EtiologyCancer PatientCause of DeathChildhoodClinical ResearchCollaborationsCommunitiesCongressesContinuity of Patient CareContractsDataData AnalysesData CollectionData CommonsDatabasesDiagnosisEcosystemEnsureFederal GovernmentFoundationsFundingGoalsGrantHealthInstitutesInstitutionLeadMalignant Childhood NeoplasmMalignant NeoplasmsMethodsModelingNational Cancer InstituteNewly DiagnosedParticipantRecommendationRegistriesResearchResearch PersonnelResearch SupportResearch TrainingResourcesSEER ProgramServicesTreatment outcomeUnited StatesVisualizationanticancer researchcancer careclinical caredata ecosystemdata ingestiondata science infrastructuredata sharingdiverse dataimprovedinfancyinteroperabilitypreventprogramsrepositorysharing platformtool
中文摘要
点击翻译按钮获取中文摘要
英文摘要
The National Cancer Institute (NCI) is the Federal government’s principal agency supporting cancer research. The Institute conducts research in its own facilities, directs research executed under contracts, and provides grant support for research and training in non-Federal institutions in the United States and abroad. One of the overarching goals of the NCI is to enhance and enable data sharing for NCI programs. CBIIT seeks to achieve this in many ways including creating a foundational platform for sharing data (Cancer Research Data Commons - CRDC) and creating new models for community-wide research, using the collaborative efforts of childhood cancer community as a model.
Childhood cancers are rare but are the leading cause of death past infancy. They make up approximately 1% of all newly diagnosed cancers and causes of most childhood cancers are not known. Adolescent and young adult (defined by NCI as between ages 15 and 39) cancers constitute 5% of all cancers, according to the NCI Surveillance, Epidemiology, and End Results (SEER) program. In December 2019, Congress approved funding for the Childhood Cancer Data Initiative (CCDI). CCDI is aimed at improving treatment and outcomes for childhood cancer patients by accelerating data collection, analysis, and sharing. Currently, data for pediatric cancer are often fragmented and stored in many separate databases, and it can be difficult for researchers and clinicians to get access. It is necessary to build a pediatric data ecosystem to maximize access, use, and interoperability of childhood cancer data and improve our ability to prevent, diagnose, and treat childhood cancer patients.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
THIS IS A CPFF TO TO REFURBISH APA BUILDINGS (1033).
-
批准号:10717450
-
项目类别:
-
资助金额:$571.96万
-
财政年份:2022
-
负责人:ETHAN DMITROVSKY
-
依托单位:
VIRTUAL RESEARCH SUPPORT PILOT
-
批准号:10717397
-
项目类别:
-
资助金额:$921.7万
-
财政年份:2022
-
负责人:ETHAN DMITROVSKY
-
依托单位:
THIS IS A CPFF TO TO REFURBISH APA BUILDINGS 1034
-
批准号:10717424
-
项目类别:
-
资助金额:$568.51万
-
财政年份:2022
-
负责人:ETHAN DMITROVSKY
-
依托单位:
CONSOLIDATED FACILITIES REQUIREMENTS FOR FY22 TASK ORDER-A.
-
批准号:10716600
-
项目类别:
-
资助金额:$227.35万
-
财政年份:2022
-
负责人:ETHAN DMITROVSKY
-
依托单位:
THIS CPFF TO IS FOR REFURBISHMENT AND INFRASTRUCTURE PROJECTS FOCUSED ON FACILITY IMPROVEMENTS WITHIN THE NCI AT FREDERICK CAMPUSMOD001
-
批准号:10717434
-
项目类别:
-
资助金额:$610.91万
-
财政年份:2022
-
负责人:ETHAN DMITROVSKY
-
依托单位:
FY22 - APA BUILDINGS - BUILDING 1
-
批准号:10717479
-
项目类别:
-
资助金额:$544.92万
-
财政年份:2022
-
负责人:ETHAN DMITROVSKY
-
依托单位:
FY22 Facilities Task Order B – Refurbishment and Infrastructure Projects focused on Facility Improvements within the NCI at Frederick Campus
-
批准号:10716465
-
项目类别:
-
资助金额:$612.82万
-
财政年份:2022
-
负责人:ETHAN DMITROVSKY
-
依托单位:
THIS COST PLUS FIXED FEE TASK ORDER IS FOR COORDINATED FACILITIES REQUIREMENTS FOR FY22 FACILITIES BAS UPGRADE
-
批准号:10717452
-
项目类别:
-
资助金额:$359.69万
-
财政年份:2022
-
负责人:ETHAN DMITROVSKY
-
依托单位:
FY22 - APA BUILDINGS - BUILDING 2
-
批准号:10717471
-
项目类别:
-
资助金额:$570.81万
-
财政年份:2022
-
负责人:ETHAN DMITROVSKY
-
依托单位:
FY22 Facilities Task Order B – Refurbishment and Infrastructure Projects focused on Facility Improvements within the NCI at Frederick Campus
-
批准号:10815678
-
项目类别:
-
资助金额:$120.16万
-
财政年份:2022
-
负责人:ETHAN DMITROVSKY
-
依托单位:
PMS2 MUTATIONS PROJECT: BIOSPECIMENS PROCUREMENT FOR CHARACTERIZATION FROM HIGH-RISK POPULATION OF CANADIAN INUIT
-
批准号:10717504
-
项目类别:
-
资助金额:$41.26万
-
财政年份:2022
-
负责人:ETHAN DMITROVSKY
-
依托单位:
THIS CPFF TO IS FOR REFURBISHMENT AND INFRASTRUCTURE PROJECTS FOCUSED ON FACILITY IMPROVEMENTS WITHIN THE NCI AT FREDERICK CAMPUSMOD001
-
批准号:10788206
-
项目类别:
-
资助金额:$8.86万
-
财政年份:2022
-
负责人:ETHAN DMITROVSKY
-
依托单位:
WEDGEWOOD EXPANSION DESIGN SUITES M & N
-
批准号:10502595
-
项目类别:
-
资助金额:$186.82万
-
财政年份:2021
-
负责人:ETHAN DMITROVSKY
-
依托单位:
WEDGEWOOD EXPANSION DESIGN SUITES M & N
-
批准号:10788097
-
项目类别:
-
资助金额:$576.97万
-
财政年份:2021
-
负责人:ETHAN DMITROVSKY
-
依托单位:
Frederick National Laboratory for Cancer Research (FNLCR) Center for SARS-CoV-2 Serological Sciences
-
批准号:10582502
-
项目类别:
-
资助金额:$5790.91万
-
财政年份:2021
-
负责人:ETHAN DMITROVSKY
-
依托单位:
CORE SUPPORT FOR THE IMMUNE CELL NETWORK
-
批准号:10502596
-
项目类别:
-
资助金额:$584.25万
-
财政年份:2021
-
负责人:ETHAN DMITROVSKY
-
依托单位:
FY22 CONSOLIDATED FACILITIES TASK ORDER C
-
批准号:10551061
-
项目类别:
-
资助金额:$136.74万
-
财政年份:2021
-
负责人:ETHAN DMITROVSKY
-
依托单位:
COORDINATING CENTER FOR THE NCI CERVICAL CANCER LAST MILE INITIATIVE SELF-SAMPLING FOR HPV TESTING TO IMPROVE CERVICAL CANCER PREVENTI
-
批准号:10498201
-
项目类别:
-
资助金额:$609.69万
-
财政年份:2021
-
负责人:ETHAN DMITROVSKY
-
依托单位:
FY21 CONSOLIDATED FACILITIES TASK ORDER A
-
批准号:10503803
-
项目类别:
-
资助金额:$148.28万
-
财政年份:2021
-
负责人:ETHAN DMITROVSKY
-
依托单位:
FY22 CONSOLIDATED FACILITIES TASK ORDER C
-
批准号:10815680
-
项目类别:
-
资助金额:$488.41万
-
财政年份:2021
-
负责人:ETHAN DMITROVSKY
-
依托单位:
国内基金
海外基金
登录
查看更多内容
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
-
批准号:JCZRLH202601523
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
-
批准号:JCZRQN202500010
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
-
批准号:2025JJ70209
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:雷芬芳
-
依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
-
批准号:--
-
项目类别:面上项目
-
资助金额:--
-
批准年份:2024
-
负责人:万荣
-
依托单位:
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
-
批准号:2023JJ50274
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:贺志明
-
依托单位:
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
-
批准号:--
-
项目类别:地区科学基金项目
-
资助金额:33万元
-
批准年份:2022
-
负责人:都义日
-
依托单位:
补肾健脾祛瘀方调控AGE/RAGE信号通路在再生障碍性贫血骨髓间充质干细胞功能受损的作用与机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:叶宝东
-
依托单位:
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2022
-
负责人:于海兵
-
依托单位:
围绕GLP1-Arginine-AGE/RAGE轴构建探针组学方法探索大柴胡汤异病同治的效应机制
-
批准号:81973577
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2019
-
负责人:辛贵忠
-
依托单位:
AGE/RAGE通路microRNA编码基因多态性与2型糖尿病并发冠心病的关联研究
-
批准号:81602908
-
项目类别:青年科学基金项目
-
资助金额:18.0万元
-
批准年份:2016
-
负责人:刘括
-
依托单位: